Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...
The former Kate Middleton was diagnosed with cancer early in 2024 ... a device implanted into the skin, which she says she became attached to. When it came time to remove it, she admitted she ...